Publications by authors named "D Kulis"
Principles of good practice for translation of electronic clinical outcome assessments.
J Patient Rep Outcomes
March 2025
Background: While many publications have outlined good practice recommendations for translation and electronic implementation of clinical outcome assessments (COAs), they are often treated as independent processes. The scientific literature currently lacks recommended guidelines on the process of concurrent translation, cultural adaptation and electronic implementation of COAs for clinical research. In response to this need, the ISOQOL Translation and Cultural Adaptation Special Interest Group (TCA-SIG) sought to identify actionable steps for addressing the scientific and operational intricacies in this concurrent process.
View Article and Find Full Text PDFPurpose: This study aims to identify a combination of clinical, demographic, and patient competence determinants of patients' communication with doctors and nurses in an international sample of cancer patients.
Methods: For our cross-sectional study, cancer patients assessed their communication with their doctors or nurses at the start of their treatment. Patients completed EORTC communication questionnaire QLQ-COMU26 to assess ten areas of communication with their doctor or nurses plus another item to assess how competent they felt when communicating with professionals.
Article Synopsis
- - The EORTC QLQ-COMU26 is a newly developed questionnaire aimed at assessing how cancer patients perceive their communication with healthcare professionals, tested for validity and reliability among a diverse international sample.
- - In a study with 498 cancer patients across 10 European countries, Japan, Jordan, and India, the questionnaire demonstrated clarity and minimal emotional distress, with strong reliability and appropriate scale structure confirmed through various assessments.
- - The QLQ-COMU26 effectively identified differences in patient experiences based on factors like sex, education, and satisfaction with communication, as well as captured changes over time related to patient interactions with healthcare providers.
Article Synopsis
- - Ostreopsis cf. ovata, a type of marine dinoflagellate, is spreading globally and causing harmful algal blooms (HABs) due to the production of toxic compounds known as ovatoxins, particularly OVTX-a.
- - The toxicity of these compounds remains unclear because there is a lack of high-purity reference materials for proper characterization and study.
- - Researchers have developed a refined isolation procedure for OVTX-a, leading to a notable increase in both yield and purity of the extracted toxin, which is essential for further research and understanding of its toxicity.
Background: There are different modes and ways to assess patient-reported outcomes (PROs) in clinical trials. However, there is little systematic information on how often different modes of assessment (MOA) are used in cancer clinical trials and how exactly assessments are conducted. The goal of this scoping review is to gain an understanding of the MOA and data management of PROs in cancer randomised controlled trials (RCTs) and the reporting quality thereof.
View Article and Find Full Text PDF